NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes

Molecular and Cellular Biochemistry

Volumn 382, Issue 1-2, 2013, Pages 185-191

  Gao, Ling ^a   Huang, Weilu ^a   Li, Jing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Advanced glycosylation end products (AGEs); Fibronectin; Human glomerular mesangial cells (HMCs); Inducible nitric oxide synthase (iNOS); Oxidative stress (OS); Transform growth factor (TGF )

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FIBRONECTIN; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBUNIT; FIBROGENESIS; GLOMERULUS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; KIDNEY; MESANGIUM; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RNA INTERFERENCE;

DIABETES MELLITUS; ENZYME INDUCTION; FIBROSIS; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; MEMBRANE GLYCOPROTEINS; MESANGIAL CELLS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID; REACTIVE OXYGEN SPECIES; SUPEROXIDES; UP-REGULATION;

EID: 84884673379     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1733-4     Document Type: Article

References (21)

1. Lopes AA (2009) End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis 19(1):47
2. Palm F, Nordquist L, Wilcox CS, Hansell P (2011) Oxidative stress and hypoxia in the pathogenesis of diabetic nephropathy. Studies on renal disorders. Humana Press, NY, pp 559-586
3. Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E (2002) Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 17(1):20-29. doi: 10.1007/s004670200004
4. Piao YJ, Seo YH, Hong F, Kim JH, Kim YJ, Kang MH, Kim BS, Jo SA, Jo I, Jue DM, Kang I, Ha J, Kim SS (2005) Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic Biol Med 38(8):989-1001. doi: 10.1016/j.freeradbiomed.2004.11.011
5. Fujii J (2011) Introduction to serial reviews: physiological relevance of antioxid/redox genes; learning from genetically modified animals. J Clin Biochem Nutr 49(2):69
6. Szabo C (2009) Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 156(5):713-727
7. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FYT, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway. Diabetes 57(2):460-469
8. Huang J, Huang K, Lan T, Xie X, Shen X, Liu P, Huang H (2013) Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. Mol Cell Endocrinol 365(2):231-240. doi: 10.1016/j.mce.2012. 10.024
9. Xie X, Peng J, Chang X, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H (2013) Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy. Mol Cell Endocrinol 369(1-2):86-97. doi: 10.1016/j.mce.2013.01.007
10. Xiao H, Li Y, Qi J, Wang H, Liu K (2009) Peroxynitrite plays a key role in glomerular lesions in diabetic rats. J Nephrol 22(6):800-808
11. Cui W, Li B, Bai Y, Miao X, Chen Q, Sun W, Tan Y, Luo P, Zhang C, Zheng S, Epstein PN, Miao L, Cai L (2013) Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice. Am J Physiol Endocrinol Metab 304(1):E87-E99. doi: 10.1152/ajpendo.00430.2012
12. Star RA (1997) Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Pharmacol Physiol 24(8):607-610
13. Pawluczyk IZA, Harris KPG (2012) Effect of angiotensin type 2 receptor over-expression on the rat mesangial cell fibrotic phenotype: effect of gender. J Renin Angiotensin Aldosterone Syst 13(2):221-231
14. Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM (2004) Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65(5):1664-1675. doi: 10.1111/j.1523-1755.2004.00602.x
15. Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H (1999) Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42:878-886
16. Wautier JL (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95(3):233-238. doi: 10.1161/01.res.0000137876.28454.64
17. Candido R (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 92(7):785-792. doi: 10.1161/01.res.0000065620.39919.20
18. Lee HB (2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14(90003):S241-S245. doi: 10.1097/01.asn.0000077410.66390.0f
19. Wu F, Tyml K, Wilson JX (2008) iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 217(1):207-214. doi: 10.1002/jcp.21495
20. Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y (2004) Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Nephrol Dial Transplant 19(12):3012-3020. doi: 10.1093/ndt/gfh499
21. Youn JY, Gao L, Cai H (2012) The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 55(7):2069-2079. doi: 10.1007/s00125-012-2557-6